1-154983791-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_025207.5(FLAD1):c.97G>A(p.Gly33Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000286 in 1,614,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_025207.5 missense
Scores
Clinical Significance
Conservation
Publications
- myopathy with abnormal lipid metabolismInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152186Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000131 AC: 33AN: 251476 AF XY: 0.000103 show subpopulations
GnomAD4 exome AF: 0.000307 AC: 449AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.000308 AC XY: 224AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152186Hom.: 0 Cov.: 31 AF XY: 0.0000673 AC XY: 5AN XY: 74342 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 33 of the FLAD1 protein (p.Gly33Arg). This variant is present in population databases (rs142890812, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with FLAD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1496588). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
In silico analysis suggests that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at